Insider Trading June 15, 2026 10:58 AM

C1 Fund Director Scott Reed Acquires Additional Shares Amid Stock Decline

Insider purchase of 4,599 shares at $3.10 signals confidence as CFND trades near 52-week low

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
CFND

Scott A. Reed, a director at C1 Fund Inc. (NASDAQ:CFND), has increased his direct ownership in the company through recent open-market purchases totaling $15,500. The transactions, executed on June 11 and 12, 2026, involved buying 4,599 shares at $3.10 per share. These purchases occur as CFND stock trades near its 52-week low of $2.85, reflecting a significant 67% decline over the past year. Following the transactions, Reed directly holds 52,000 shares, with an additional 65,500 shares held indirectly through the WA Reed Family 2015 Trust. The stock currently trades at $3.18, with a market capitalization of $21.11 million. According to InvestingPro, which offers additional exclusive insights for CFND, the company maintains a weak overall financial health score.

C1 Fund Director Scott Reed Acquires Additional Shares Amid Stock Decline
CFND
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Director Scott A. Reed acquired 4,599 shares of C1 Fund common stock on June 12, 2026, at a price of $3.10 per share. This follows his purchase of 401 shares on June 11, 2026.
  • CFND stock is trading near its 52-week low of $2.85, representing a 67% decline over the past year. The stock currently trades at $3.18 with a market cap of $21.11 million.
  • Reed's total direct holdings in C1 Fund stand at 52,000 shares, while he also holds 65,500 shares indirectly through the WA Reed Family 2015 Trust.

Scott A. Reed, a director at C1 Fund Inc. (NASDAQ:CFND), has increased his direct ownership in the company through recent open-market purchases totaling $15,500. The transactions, executed on June 11 and 12, 2026, involved buying 4,599 shares at $3.10 per share. These purchases occur as CFND stock trades near its 52-week low of $2.85, reflecting a significant 67% decline over the past year. Following the transactions, Reed directly holds 52,000 shares, with an additional 65,500 shares held indirectly through the WA Reed Family 2015 Trust. The stock currently trades at $3.18, with a market capitalization of $21.11 million. According to InvestingPro, which offers additional exclusive insights for CFND, the company maintains a weak overall financial health score.

Key Points:

  • Director Scott A. Reed acquired 4,599 shares of C1 Fund common stock on June 12, 2026, at a price of $3.10 per share. This follows his purchase of 401 shares on June 11, 2026.
  • CFND stock is trading near its 52-week low of $2.85, representing a 67% decline over the past year. The stock currently trades at $3.18 with a market cap of $21.11 million.
  • Reed's total direct holdings in C1 Fund stand at 52,000 shares, while he also holds 65,500 shares indirectly through the WA Reed Family 2015 Trust.

Risks and Uncertainties:

  • The company's weak overall financial health score, as noted by InvestingPro, raises questions about its stability and future performance.
  • The significant decline in CFND stock price over the past year may indicate broader market challenges or sector-specific pressures.
  • Investor confidence in C1 Fund may be influenced by the company's financial health, potentially impacting its ability to attract capital or execute strategic initiatives.

Sector and Market Impact:

The transactions in C1 Fund stock may have implications for the small-cap investment sector, particularly as insider activity can signal management's confidence in the company's future prospects. The weak financial health score and declining stock price suggest potential challenges for the company, which could affect investor sentiment in similar small-cap investment vehicles. Additionally, the insider purchase may be viewed as a positive signal for other investors, potentially stabilizing the stock price in the short term.

Conclusion:

Scott A. Reed's recent share purchases in C1 Fund Inc. highlight his continued confidence in the company despite the stock's recent decline. With a total direct and indirect holding of 117,500 shares, Reed's actions may be closely watched by other investors and analysts. The company's weak financial health score and the stock's proximity to its 52-week low underscore the importance of monitoring CFND's future developments closely.

Risks

  • The company's weak overall financial health score, as noted by InvestingPro, raises questions about its stability and future performance.
  • The significant decline in CFND stock price over the past year may indicate broader market challenges or sector-specific pressures.
  • Investor confidence in C1 Fund may be influenced by the company's financial health, potentially impacting its ability to attract capital or execute strategic initiatives.

More from Insider Trading

Block Director Executes Pre-Arranged Sale as Analysts Adjust Pricing Models Ahead of Q2 Earnings Jul 30, 2026 Viking Therapeutics Executive Liquidates Shares to Cover Vesting Tax Obligations Jul 29, 2026 TransUnion Executive Sells Equity as Q2 Earnings Beat Consensus Estimates Jul 29, 2026 Tenet Healthcare Director James Bierman Offloads $1.22 Million in Shares Amid Strong Earnings Backdrop Jul 28, 2026 Portland General Electric Director Executes Strategic Share Transactions Amid Earnings Recalibration Jul 28, 2026